Alkermes PLC Company Profile (NASDAQ:ALKS)

About Alkermes PLC

Alkermes PLC logoAlkermes Public Limited Company is a biopharmaceutical company. The Company is engaged in researching, developing and commercializing, both with partners and on its own, pharmaceutical products that are designed to address medical needs of patients in therapeutic areas. The Company has a portfolio of approximately 20 products and a clinical pipeline of product candidates that address central nervous system (CNS) disorders, such as schizophrenia, depression, addiction and multiple sclerosis. Its products include ARISTADA, VIVITROL, RISPERDAL CONSTA, INVEGA SUSTENNA/XEPLION & INVEGA TRINZA, AMPYRA/FAMPYRA, BYDUREON, ALKS 5461, ALKS 3831, ALKS 8700, ALKS 6428, Aripiprazole Lauroxil Two-Month Dose, ALKS 7119 and RDB 1450. Its product platforms include injectable extended-release microsphere technology, LinkeRx technology, NanoCrystal technology and oral controlled release technology.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Delivery
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: ALKS
  • CUSIP: G0176710
Key Metrics:
  • Previous Close: $43.51
  • 50 Day Moving Average: $46.64
  • 200 Day Moving Average: $44.48
  • 52-Week Range: $27.14 - $80.71
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -82.09
  • P/E Growth: 13.62
  • Market Cap: $6.59B
  • Outstanding Shares: 151,556,000
  • Beta: 2.05
  • Net Margins: -41.19%
  • Return on Equity: -14.18%
  • Return on Assets: -10.06%
  • Debt-to-Equity Ratio: 0.23%
  • Current Ratio: 3.93%
  • Quick Ratio: 3.72%
Additional Links:
Companies Related to Alkermes PLC:

Analyst Ratings

Consensus Ratings for Alkermes PLC (NASDAQ:ALKS) (?)
Ratings Breakdown: 3 Hold Ratings, 7 Buy Ratings
Consensus Rating:Buy (Score: 2.70)
Consensus Price Target: $60.22 (38.41% upside)

Analysts' Ratings History for Alkermes PLC (NASDAQ:ALKS)
DateFirmActionRatingPrice TargetDetails
10/21/2016Morgan StanleyUpgradeUnderweight -> Equal WeightView Rating Details
10/21/2016Jefferies GroupBoost Price TargetBuy$62.00 -> $70.00View Rating Details
10/21/2016Leerink SwannBoost Price TargetOutperform$57.00 -> $70.00View Rating Details
10/21/2016Credit Suisse Group AGBoost Price Target$70.00View Rating Details
10/21/2016JPMorgan Chase & Co.UpgradeNeutral -> Overweight$78.00View Rating Details
9/27/2016Citigroup Inc.Boost Price TargetNeutral$44.00 -> $53.00View Rating Details
9/23/2016Cowen and CompanyReiterated RatingBuyView Rating Details
7/29/2016Barclays PLCBoost Price TargetOverweight$65.00 -> $66.00View Rating Details
5/26/2016Evercore ISIInitiated CoverageBuy$59.00View Rating Details
2/22/2016Goldman Sachs Group Inc.Lower Price Target$57.00 -> $35.00View Rating Details
1/21/2016GuggenheimReiterated RatingHoldView Rating Details
2/25/2015Bank of America Corp.Set Price TargetSell$45.00View Rating Details
1/8/2015MizuhoBoost Price TargetBuy$72.00 -> $81.00View Rating Details
(Data available from 10/21/2014 forward)


Earnings History for Alkermes PLC (NASDAQ:ALKS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/28/2016Q216($0.10)($0.01)$174.15 million$195.20 millionViewListenView Earnings Details
4/28/2016Q116($0.20)($0.16)$153.64 million$156.80 millionViewListenView Earnings Details
2/25/2016Q415($0.18)($0.15)$161.24 million$163.10 millionViewListenView Earnings Details
10/29/2015Q315($0.21)($0.18)$151.77 million$152.70 millionViewListenView Earnings Details
7/30/2015Q215($0.10)($0.09)$142.80 million$151.40 millionViewListenView Earnings Details
4/30/2015Q115($0.03)$0.06$146.60 million$161.20 millionViewListenView Earnings Details
2/24/2015Q414$0.04$0.11$161.70 million$175.20 millionViewListenView Earnings Details
10/29/2014Q314$0.02$0.03$155.53 million$160.00 millionViewListenView Earnings Details
7/31/2014Q314$0.14$0.11$146.91 million$153.40 millionViewListenView Earnings Details
4/30/2014Q1$0.10$0.11$135.79 million$130.21 millionViewListenView Earnings Details
2/27/2014Q114$0.20$0.27$142.93 million$154.50 millionViewListenView Earnings Details
10/31/2013$0.22$0.22$137.35 million$139.80 millionViewListenView Earnings Details
7/25/2013Q1 2014$0.22$0.30$131.50 million$138.60 millionViewListenView Earnings Details
5/23/2013Q4 2013$0.17$0.40$128.01 million$163.40 millionViewListenView Earnings Details
1/31/2013Q3 2013$0.23$0.34$130.81 million$135.90 millionViewListenView Earnings Details
11/1/2012Q213$0.11$0.17$121.62 million$124.00 millionViewN/AView Earnings Details
7/26/2012$0.16$0.39ViewN/AView Earnings Details
5/17/2012($0.16)($0.14)ViewN/AView Earnings Details
2/2/2012($0.21)($0.11)ViewN/AView Earnings Details
11/3/2011($0.10)($0.22)ViewN/AView Earnings Details
8/1/2011($0.11)$0.02ViewN/AView Earnings Details
5/18/2011($0.14)($0.14)ViewN/AView Earnings Details
2/3/2011($0.15)($0.06)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Alkermes PLC (NASDAQ:ALKS)
Current Year EPS Consensus Estimate: $-0.89 EPS
Next Year EPS Consensus Estimate: $-0.53 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20161($0.16)($0.16)($0.16)
Q3 20162($0.33)($0.17)($0.25)
Q4 20161($0.14)($0.14)($0.14)
(Data provided by Zacks Investment Research)


Dividend History for Alkermes PLC (NASDAQ:ALKS)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Alkermes PLC (NASDAQ:ALKS)
Insider Ownership Percentage: 4.75%
Institutional Ownership Percentage: 95.11%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/4/2016Paul J MitchellDirectorSell2,000$47.42$94,840.00View SEC Filing  
9/22/2016Elliot EhrichCMOSell5,000$50.83$254,150.00View SEC Filing  
9/16/2016Elliot EhrichCMOSell5,000$48.87$244,350.00View SEC Filing  
9/6/2016David Joseph GaffinSVPSell2,382$45.92$109,381.44View SEC Filing  
9/6/2016Elliot EhrichCMOSell10,000$46.02$460,200.00View SEC Filing  
9/6/2016Iain Michael BrownCAOSell29,976$45.92$1,376,497.92View SEC Filing  
9/6/2016Paul J MitchellDirectorSell2,000$45.92$91,840.00View SEC Filing  
8/4/2016Paul J MitchellDirectorSell2,000$49.48$98,960.00View SEC Filing  
7/27/2016Elliot EhrichCMOSell35,199$51.95$1,828,588.05View SEC Filing  
7/5/2016Paul J MitchellDirectorSell2,000$45.81$91,620.00View SEC Filing  
6/6/2016Paul J MitchellDirectorSell2,000$44.98$89,960.00View SEC Filing  
5/4/2016Paul J MitchellDirectorSell2,000$38.60$77,200.00View SEC Filing  
4/20/2016Michael J LandineSVPSell16,875$41.09$693,393.75View SEC Filing  
4/19/2016Richard F PopsCEOSell18,750$40.15$752,812.50View SEC Filing  
4/18/2016Iain Michael BrownCAOSell5,368$39.27$210,801.36View SEC Filing  
4/13/2016Elliot EhrichCMOSell11,698$37.66$440,546.68View SEC Filing  
4/12/2016Richard F PopsCEOSell25,000$37.79$944,750.00View SEC Filing  
4/4/2016Paul J MitchellDirectorSell2,000$35.65$71,300.00View SEC Filing  
3/22/2016Richard F PopsCEOSell25,000$31.77$794,250.00View SEC Filing  
3/15/2016Richard F PopsCEOSell25,000$31.40$785,000.00View SEC Filing  
3/4/2016Paul J MitchellDirectorSell2,000$32.80$65,600.00View SEC Filing  
3/3/2016David W AnsticeDirectorBuy5,000$32.87$164,350.00View SEC Filing  
2/4/2016Paul J. MitchellDirectorSell2,000$32.81$65,620.00View SEC Filing  
1/4/2016Robert A BreyerDirectorSell2,000$77.33$154,660.00View SEC Filing  
12/28/2015Mark StejbachinsiderSell10,000$80.24$802,400.00View SEC Filing  
12/23/2015Shane CookeinsiderSell18,000$77.23$1,390,140.00View SEC Filing  
12/7/2015Michael J. LandineSVPSell3,750$73.02$273,825.00View SEC Filing  
12/7/2015Richard F. PopsCEOSell37,500$72.06$2,702,250.00View SEC Filing  
12/1/2015Mark StejbachinsiderSell18,000$72.18$1,299,240.00View SEC Filing  
12/1/2015Michael J. LandineSVPSell10,000$72.18$721,800.00View SEC Filing  
12/1/2015Richard F. PopsCEOSell50,000$72.29$3,614,500.00View SEC Filing  
12/1/2015Robert A BreyerDirectorSell2,000$73.46$146,920.00View SEC Filing  
11/23/2015Shane CookeinsiderSell18,000$72.62$1,307,160.00View SEC Filing  
11/2/2015Mark StejbachinsiderSell18,000$72.06$1,297,080.00View SEC Filing  
11/2/2015Robert A BreyerDirectorSell2,000$71.80$143,600.00View SEC Filing  
10/29/2015Iain Michael BrownCAOSell10,822$69.99$757,431.78View SEC Filing  
10/23/2015Shane CookeinsiderSell18,000$62.03$1,116,540.00View SEC Filing  
10/13/2015James M. FratesCFOSell20,000$59.78$1,195,600.00View SEC Filing  
10/2/2015Robert A. BreyerDirectorSell2,000$60.00$120,000.00View SEC Filing  
9/23/2015Shane CookeinsiderSell18,000$67.09$1,207,620.00View SEC Filing  
9/17/2015Michael J. LandineSVPSell10,000$71.20$712,000.00View SEC Filing  
9/17/2015Richard F. PopsCEOSell50,000$71.27$3,563,500.00View SEC Filing  
9/15/2015James M. FratesCFOSell20,000$71.10$1,422,000.00View SEC Filing  
9/10/2015Michael J. LandineSVPSell10,000$67.61$676,100.00View SEC Filing  
9/10/2015Richard F. PopsCEOSell50,000$67.57$3,378,500.00View SEC Filing  
9/1/2015Robert A BreyerDirectorSell2,000$61.43$122,860.00View SEC Filing  
8/24/2015Shane CookeinsiderSell18,000$57.65$1,037,700.00View SEC Filing  
7/23/2015Shane CookeInsiderSell18,000$69.79$1,256,220.00View SEC Filing  
7/20/2015Gordon G PughCOOSell18,750$70.10$1,314,375.00View SEC Filing  
7/14/2015James M FratesCFOSell20,000$65.79$1,315,800.00View SEC Filing  
7/1/2015Gordon G PughCOOSell13,750$65.13$895,537.50View SEC Filing  
7/1/2015Robert A BreyerDirectorSell2,000$64.90$129,800.00View SEC Filing  
6/23/2015Shane CookeInsiderSell18,000$66.84$1,203,120.00View SEC Filing  
6/17/2015Paul J MitchellDirectorSell15,500$65.10$1,009,050.00View SEC Filing  
6/16/2015Gordon G PughCOOSell32,977$63.11$2,081,178.47View SEC Filing  
6/16/2015James M FratesCFOSell10,000$58.63$586,300.00View SEC Filing  
6/1/2015Paul J MitchellDirectorSell1,500$60.78$91,170.00View SEC Filing  
6/1/2015Rebecca PetersonSVPSell21,983$60.05$1,320,079.15View SEC Filing  
5/26/2015Rebecca PetersonSVPSell1,322$60.49$79,967.78View SEC Filing  
5/26/2015Shane CookeInsiderSell18,000$60.31$1,085,580.00View SEC Filing  
5/22/2015Rebecca PetersonSVPSell28,558$61.71$1,762,314.18View SEC Filing  
5/12/2015James M FratesCFOSell10,000$59.34$593,400.00View SEC Filing  
5/4/2015Robert A BreyerDirectorSell2,000$60.00$120,000.00View SEC Filing  
5/1/2015Paul J MitchellDirectorSell1,500$55.79$83,685.00View SEC Filing  
4/23/2015Shane CookeInsiderSell18,000$62.55$1,125,900.00View SEC Filing  
4/21/2015Elliot EhrichCMOSell25,000$62.39$1,559,750.00View SEC Filing  
4/15/2015Gordon G PughCOOSell13,750$63.21$869,137.50View SEC Filing  
4/15/2015James M FratesCFOSell10,000$62.42$624,200.00View SEC Filing  
4/15/2015Paul J MitchellDirectorSell1,500$62.71$94,065.00View SEC Filing  
4/1/2015Robert A BreyerDirectorSell5,000$61.22$306,100.00View SEC Filing  
3/23/2015Shane CookeInsiderSell18,000$65.33$1,175,940.00View SEC Filing  
3/16/2015Elliot EhrichCMOSell18,000$66.81$1,202,580.00View SEC Filing  
3/10/2015James M FratesCFOSell10,000$66.25$662,500.00View SEC Filing  
3/5/2015Rebecca PetersonSVPSell17,737$71.37$1,265,889.69View SEC Filing  
3/2/2015Gordon G PughCOOSell15,000$71.39$1,070,850.00View SEC Filing  
3/2/2015Robert A BreyerDirectorSell5,000$70.86$354,300.00View SEC Filing  
2/23/2015Shane CookeInsiderSell18,000$74.29$1,337,220.00View SEC Filing  
2/17/2015Elliot EhrichCMOSell18,000$70.87$1,275,660.00View SEC Filing  
2/3/2015James M FratesCFOSell10,000$70.83$708,300.00View SEC Filing  
2/2/2015Gordon G PughCOOSell15,000$72.01$1,080,150.00View SEC Filing  
2/2/2015Robert A BreyerDirectorSell5,000$72.91$364,550.00View SEC Filing  
1/26/2015Gordon G PughCOOSell15,000$70.02$1,050,300.00View SEC Filing  
1/23/2015Shane CookeInsiderSell118,000$69.13$8,157,340.00View SEC Filing  
1/16/2015Floyd E BloomDirectorSell20,000$67.12$1,342,400.00View SEC Filing  
1/15/2015Elliot EhrichCMOSell18,375$66.45$1,221,018.75View SEC Filing  
1/15/2015James M FratesCFOSell10,000$66.86$668,600.00View SEC Filing  
1/7/2015Kathryn L BibersteinSVPSell28,374$65.00$1,844,310.00View SEC Filing  
1/2/2015Robert A BreyerDirectorSell5,000$58.57$292,850.00View SEC Filing  
12/11/2014Richard F PopsCEOSell100,000$56.04$5,604,000.00View SEC Filing  
12/10/2014James M FratesCFOSell18,870$56.07$1,058,040.90View SEC Filing  
12/9/2014Michael J LandineSVPSell18,000$56.82$1,022,760.00View SEC Filing  
12/5/2014Kathryn L BibersteinSVPSell15,433$57.61$889,095.13View SEC Filing  
12/1/2014Robert A BreyerDirectorSell5,000$54.64$273,200.00View SEC Filing  
11/19/2014James M FratesCFOSell8,000$53.86$430,880.00View SEC Filing  
11/13/2014Richard F PopsCEOSell100,000$52.87$5,287,000.00View SEC Filing  
11/7/2014James M FratesCFOSell13,303$49.98$664,883.94View SEC Filing  
11/6/2014Kathryn L BibersteinSVPSell20,000$50.54$1,010,800.00View SEC Filing  
11/3/2014Robert A BreyerDirectorSell5,000$50.05$250,250.00View SEC Filing  
10/23/2014Gordon G PughCOOSell14,577$45.00$655,965.00View SEC Filing  
10/8/2014James M FratesCFOSell16,000$41.00$656,000.00View SEC Filing  
10/1/2014Robert A BreyerDirectorSell5,000$42.59$212,950.00View SEC Filing  
9/24/2014James M FratesCFOSell16,000$45.29$724,640.00View SEC Filing  
9/18/2014Michael J LandineSVPSell15,000$45.60$684,000.00View SEC Filing  
9/17/2014Gordon G PughCOOSell14,900$45.04$671,096.00View SEC Filing  
9/17/2014Richard F PopsCEOSell50,000$44.89$2,244,500.00View SEC Filing  
9/10/2014James M FratesCFOSell16,000$43.18$690,880.00View SEC Filing  
9/2/2014Gordon G PughCOOSell1,100$45.08$49,588.00View SEC Filing  
9/2/2014Robert A BreyerDirectorSell5,000$45.12$225,600.00View SEC Filing  
8/27/2014James M FratesCFOSell16,000$45.08$721,280.00View SEC Filing  
8/26/2014Gordon G PughCOOSell16,000$45.00$720,000.00View SEC Filing  
8/13/2014James M FratesCFOSell15,000$41.37$620,550.00View SEC Filing  
8/11/2014Elliot EhrichCMOSell16,667$41.65$694,180.55View SEC Filing  
8/4/2014Gordon G PughCOOSell23,250$43.20$1,004,400.00View SEC Filing  
8/1/2014Robert A BreyerDirectorSell5,000$42.53$212,650.00View SEC Filing  
7/16/2014James M FratesCFOSell8,000$46.50$372,000.00View SEC Filing  
7/9/2014Elliot EhrichCMOSell16,667$47.41$790,182.47View SEC Filing  
7/9/2014James M FratesCFOSell7,000$47.41$331,870.00View SEC Filing  
7/3/2014Michael J LandineSVPSell7,000$51.31$359,170.00View SEC Filing  
7/2/2014Richard F PopsCEOSell50,000$51.69$2,584,500.00View SEC Filing  
7/1/2014Gordon G PughCOOSell16,000$46.49$743,840.00View SEC Filing  
7/1/2014Robert A BreyerDirectorSell5,000$50.57$252,850.00View SEC Filing  
6/26/2014Michael J LandineSVPSell10,000$49.92$499,200.00View SEC Filing  
6/25/2014James M FratesCFOSell7,000$50.22$351,540.00View SEC Filing  
6/25/2014Richard F PopsCEOSell50,000$49.87$2,493,500.00View SEC Filing  
6/20/2014Paul J MitchellDirectorSell17,000$50.00$850,000.00View SEC Filing  
6/19/2014Elliot EhrichCMOSell17,282$47.10$813,982.20View SEC Filing  
6/19/2014Michael J LandineSVPSell10,000$47.01$470,100.00View SEC Filing  
6/18/2014Richard F PopsCEOSell50,000$46.72$2,336,000.00View SEC Filing  
6/17/2014Kathryn L BibersteinSVPSell8,400$47.41$398,244.00View SEC Filing  
6/11/2014James M FratesCFOSell7,000$47.72$334,040.00View SEC Filing  
6/9/2014Elliot EhrichCMOSell16,667$48.15$802,516.05View SEC Filing  
6/2/2014Gordon G PughCOOSell16,000$45.34$725,440.00View SEC Filing  
6/2/2014Robert A BreyerDirectorSell5,000$45.18$225,900.00View SEC Filing  
5/30/2014Rebecca PetersonSVPSell21,981$45.86$1,008,048.66View SEC Filing  
5/23/2014Rebecca PetersonSVPSell1,321$45.08$59,550.68View SEC Filing  
5/22/2014Elliot EhrichCMOSell2,378$44.49$105,797.22View SEC Filing  
5/22/2014Gordon PughCOOSell15,700$45.25$710,425.00View SEC Filing  
5/22/2014Rebecca PetersonSVPSell19,807$44.02$871,904.14View SEC Filing  
5/21/2014Elliot EhrichCMOSell1,981$44.00$87,164.00View SEC Filing  
5/21/2014James FratesCFOSell7,000$44.30$310,100.00View SEC Filing  
5/20/2014Rebecca PetersonSVPSell20,307$44.05$894,523.35View SEC Filing  
5/19/2014Elliot EhrichCMOSell2,206$43.55$96,071.30View SEC Filing  
5/8/2014Floyd BloomDirectorSell10,000$46.16$461,600.00View SEC Filing  
5/5/2014Robert BreyerDirectorSell5,000$46.72$233,600.00View SEC Filing  
5/1/2014Paul MitchellDirectorSell1,000$45.90$45,900.00View SEC Filing  
4/9/2014James FratesCFOSell7,000$42.91$300,370.00View SEC Filing  
4/1/2014Paul MitchellDirectorSell1,500$44.14$66,210.00View SEC Filing  
3/19/2014James FratesCFOSell7,000$46.84$327,880.00View SEC Filing  
3/11/2014Wendy DixonDirectorBuy1,600$47.37$75,792.00View SEC Filing  
3/5/2014James FratesCFOSell7,000$47.78$334,460.00View SEC Filing  
2/18/2014Elliot EhrichCMOSell7,718$52.45$404,809.10View SEC Filing  
2/3/2014Paul MitchellDirectorSell1,500$48.15$72,225.00View SEC Filing  
1/21/2014Elliot EhrichCMOSell7,718$48.61$375,171.98View SEC Filing  
1/16/2014Elliot EhrichCMOSell14,555$47.35$689,179.25View SEC Filing  
1/16/2014Gordon PughCOOSell30,000$47.16$1,414,800.00View SEC Filing  
1/16/2014James FratesCFOSell7,000$47.40$331,800.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Alkermes PLC (NASDAQ:ALKS)
News IconAlkermes plc (NASDAQ:ALKS) lost about -16 percent in value since ... - The Independent Republic (NASDAQ:ALKS) - October 20 at 9:19 PM logoAlkermes plc (ALKS) Announces Third ALKS 5461 Phase 3 Met ... - (NASDAQ:ALKS) - October 20 at 9:19 PM logo[$$] Alkermes Shares Surge (NASDAQ:ALKS) - October 20 at 9:19 PM
News IconShare Value Diminishing Over Past Month: Alkermes plc (NASDAQ:ALKS) - CSZ News (NASDAQ:ALKS) - October 16 at 8:13 AM logoAlkermes Plc (NASDAQ:ALKS) Files An 8-K (NASDAQ:ALKS) - October 14 at 3:24 PM
News IconUpdate on Alkermes plc (NASDAQ:ALKS) for the day (NASDAQ:ALKS) - October 14 at 3:24 PM logoALKERMES PLC. Files SEC form 8-K, Entry into a Material Definitive Agreement (NASDAQ:ALKS) - October 13 at 8:48 PM
News IconNotable Ownership Action: Alkermes PLC (NASDAQ:ALKS) Institutional Investors Quarterly Sentiment - Post News (NASDAQ:ALKS) - October 12 at 6:57 AM
News IconAlkermes plc (NASDAQ:ALKS) Earnings Preview: Should Investors Be Nervous? - The Voice Registrar (NASDAQ:ALKS) - October 12 at 6:57 AM
News IconAlkermes plc (NASDAQ:ALKS) missed earnings on 6 occasions - The Independent Republic (NASDAQ:ALKS) - October 10 at 3:23 PM
News IconLatest Analyst Ratings For Alkermes Plc (NASDAQ:ALKS) - The De ... - The De Soto Edge (NASDAQ:ALKS) - October 9 at 3:22 PM logoAlkermes Commences Metabolic Study on Schizophrenia Drug (NASDAQ:ALKS) - October 5 at 8:14 AM logoAlkermes plc (NASDAQ:ALKS) Sell Recommendations At 0 - Investor Newswire (NASDAQ:ALKS) - October 4 at 3:26 PM logoRecro Pharma Offers A Non-Opioid Alternative For Pain Management; Brean Assumes With Buy Rating - Benzinga (NASDAQ:ALKS) - October 3 at 3:23 PM logoAlkermes plc (ALKS) Commences ALKS 3831 Metabolic Profile Study as Schizophrenia Treatment - (NASDAQ:ALKS) - October 3 at 3:23 PM logoAlkermes Announces Initiation of Clinical Study Evaluating Metabolic Profile of ALKS 3831 for Treatment of Schizophrenia (NASDAQ:ALKS) - October 3 at 8:13 AM
News IconCurrent Price Targets For Alkermes Plc (NASDAQ:ALKS) - NewsDen - NewsDen (NASDAQ:ALKS) - October 2 at 3:24 PM logoAlkermes Plc breached its 50 day moving average in a Bearish Manner : ALKS-US : September 30, 2016 (NASDAQ:ALKS) - September 30 at 8:35 AM
News IconAlkermes PLC (ALKS) Stock Trending Up After Target Price Increase by Analysts at Citigroup Inc. - BNB Daily (blog) (NASDAQ:ALKS) - September 29 at 8:12 AM logoCan Shares Of Alkermes plc (NASDAQ:ALKS) Hit $66? - Investor Newswire (NASDAQ:ALKS) - September 28 at 3:24 PM logoAlkermes plc (ALKS) - Citigroup Maintains Rating And Lowers Price Target - Finance Daily (NASDAQ:ALKS) - September 27 at 3:27 PM logoCramer's Stop Trading: GILD, GWPH & ALKS (NASDAQ:ALKS) - September 27 at 3:27 PM logoJim Cramer -- Gilead Needs to Make an Acquisition (NASDAQ:ALKS) - September 27 at 3:27 PM logoVirgin Extends Drop As Alaska Air Merger Review Grows Longer (NASDAQ:ALKS) - September 23 at 3:52 PM logoAlkermes plc (NASDAQ:ALKS) Trading Up – Insiders Selling, Short Interest Growing (NASDAQ:ALKS) - September 23 at 8:15 AM
News IconTop Earnings to Watch for: Alkermes plc (NASDAQ:ALKS) - The Voice Registrar (NASDAQ:ALKS) - September 22 at 9:18 AM logoALKERMES PLC. Files SEC form 8-K/A, Change in Directors or Principal Officers (NASDAQ:ALKS) - September 21 at 9:34 AM logoAlkermes Announces Webcast of Analyst and Investor Event on September 26, 2016 (NASDAQ:ALKS) - September 19 at 4:23 PM
News IconLooking Ahead for Alkermes plc (NASDAQ:ALKS); Are These Shares Ready to Go Higher? - Frisco Fastball (NASDAQ:ALKS) - September 18 at 3:23 PM
News IconWhat is the Sell-side Saying About Alkermes plc (NASDAQ:ALKS)? - Frisco Fastball (NASDAQ:ALKS) - September 16 at 3:26 PM
News IconStock Seeing Accelerated Sales Growth Quarter over Quarter: Alkermes plc (NASDAQ:ALKS) - Post News (NASDAQ:ALKS) - September 15 at 8:36 PM logoMoving Average Crossover Alert: Alkermes (ALKS) (NASDAQ:ALKS) - September 15 at 12:21 PM
News IconSell-side is Weighing in on Alkermes plc (NASDAQ:ALKS) Earnings - Frisco Fastball (NASDAQ:ALKS) - September 14 at 8:43 PM
News IconAlkermes Plc Ord (NASDAQ:ALKS) Short Interest Increased By 11.15% - Frisco Fastball (NASDAQ:ALKS) - September 14 at 3:27 PM
News IconShares Holding Above Moving Averages: Alkermes plc (NASDAQ:ALKS) - Post News (NASDAQ:ALKS) - September 14 at 3:27 PM logoCan Shares Of Alkermes plc (NASDAQ:ALKS) Hit $66 - Investor Newswire (NASDAQ:ALKS) - September 13 at 3:26 PM
News IconShares Gapping Lower Before the Bell: Alkermes plc (NASDAQ:ALKS) - Post News (NASDAQ:ALKS) - September 12 at 3:26 PM
News IconStock Trading Above Moving Averages: Alkermes plc (NASDAQ:ALKS) - Post News (NASDAQ:ALKS) - September 12 at 3:26 PM logoALKERMES™ Inspiration Grants Application (NASDAQ:ALKS) - September 12 at 8:14 AM logoAlkermes Launches Competitive Grants Program to Support People Affected by Mental Health and Substance Use Disorders (NASDAQ:ALKS) - September 12 at 8:14 AM logoEarnings Surprise In Focus: Alkermes plc (NASDAQ:ALKS) - Investor Newswire (NASDAQ:ALKS) - September 10 at 8:12 AM logoAlkermes Injectable Technologies In Schizophrenia Will Improve Its ... - Seeking Alpha (NASDAQ:ALKS) - September 10 at 8:12 AM logoAlkermes Plc – Value Analysis (NASDAQ:ALKS) : September 9, 2016 (NASDAQ:ALKS) - September 9 at 3:25 PM
News IconPlacing Alkermes plc (NASDAQ:ALKS) Shares Under the Microscope - Post News (NASDAQ:ALKS) - September 8 at 3:25 PM logoAlkermes Plc breached its 50 day moving average in a Bullish Manner : ALKS-US : September 8, 2016 (NASDAQ:ALKS) - September 8 at 11:34 AM
News IconAlkermes PLC (NASDAQ: ALKS) Stock Rating Reiterated at Morgan Stanley - BNB Daily (blog) (NASDAQ:ALKS) - September 6 at 8:11 AM
News IconStock in Review: Taking a Closer Look at Alkermes plc (NASDAQ:ALKS) Shares - Post News (NASDAQ:ALKS) - September 1 at 3:25 PM logoETF’s with exposure to Alkermes Plc : August 25, 2016 (NASDAQ:ALKS) - August 25 at 3:28 PM logoAlkermes Plc breached its 50 day moving average in a Bullish Manner : ALKS-US : August 24, 2016 (NASDAQ:ALKS) - August 24 at 11:43 AM logoAlkermes plc (NASDAQ:ALKS) Gets 0 Recommendations To Sell - Investor Newswire (NASDAQ:ALKS) - August 23 at 3:26 PM


Alkermes PLC (NASDAQ:ALKS) Chart for Friday, October, 21, 2016

Last Updated on 10/21/2016 by Staff